Johnson & Johnson Expects FY23 Adjusted EPS Of $10.07–$10.13 Versus Prior range Of $10.00–$10.10 And Consensus Of $10.03
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson has revised its FY23 adjusted EPS forecast to $10.07-$10.13, up from the previous range of $10.00-$10.10. This new estimate surpasses the consensus of $10.03.
October 17, 2023 | 10:29 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Johnson & Johnson has increased its FY23 adjusted EPS forecast, which now exceeds the consensus estimate.
Johnson & Johnson's upward revision of its FY23 adjusted EPS forecast indicates a positive outlook for the company's future earnings. This could lead to increased investor confidence and potentially a rise in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100